BioSpace News Archive

First-quarter revenue $2,684 million and Adjusted EBITDA $587 million

Tetraphase Pharmaceuticals, Inc. announced that company management will host a conference call at 4:30 p.m. ET on Wednesday, May 8, 2019 to discuss the Company’s first quarter 2019 financial results and provide a general corporate update.

New company to positively impact the lives of millions of students globally

Two pitch events highlight the 16th Annual Summit, with deadlines on May 10 and 17

MYOS RENS Technology Inc. (“MYOS” or “the Company”) (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin®, a proprietary bioactive composition derived from fertilized egg yolk that helps build lean muscle, announced today that it will provide financial results for the first quarter 2019 on Wednesday, May 8, 2019 after the market closes.

From new technology to sustainable solutions that create more efficient and comfortable buildings, Sodexo’s Vice President of Facilities Management, Eric Jouane, names the top trends in facilities management to watch for in 2019.

Replaceable Treatment Cartridge Paves the way for Future Recurring Revenue Stream [01-May-2019] HOUSTON , May 1, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) (“Soliton” or the “Company”), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center (“MD Anderson”), to

Young Innovations, a leading global supplier of dental products, today announced the acquisition of assets from several entities which compose Crystal Tips (“Crystal Tips”)

TARIS Bio™, a biopharmaceutical company developing transformational therapies to treat people with debilitating urological disorders, announced today the initiation of a new clinical investigation of TAR-302 for the treatment of overactive bladder (OAB).

Citius Pharmaceuticals, Inc. (“Citius”) (Nasdaq: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, announced today that the Company will present at the ThinkEquity Conference on Thursday, May 2, 2019 at 8:30AM ET.